Summary
Updated Aug 30, 2026
David Ross Parkinson is President and CEO, Director of ESSA Pharma Inc. (EPIX). 1 SEC Form 4 filing on record, dated 9 October 2025.
Recent Transactions
1Every recent SEC Form 4 transaction David Ross Parkinson has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as David Ross Parkinson. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Growth N. V. Biotech - $12.02M of EPIX open-market activity on record
- Peter Virsik - $4K of EPIX open-market activity on record
- BVF PARTNERS L P - $293 of EPIX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David Ross Parkinson?
David Ross Parkinson is a corporate insider, tracked as President and CEO, Director of ESSA Pharma Inc. (EPIX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David Ross Parkinson last file a Form 4?
The only primary Form 4 on record is dated 9 October 2025.
Where can I see all of David Ross Parkinson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David Ross Parkinson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
